From 2008 to today, assets under management for activists hedge funds increased from $32 billion to over $117.6 billion. Activist investors now pose threats to all public companies, no matter the size or industry. Goodwin’s activist defense team has over 30 years of experience in designing strategies to protect public companies of all types and sizes from activist attacks. In the last several years, Goodwin has defended multiple clients from attacks from the world’s biggest activism funds such as Elliot Management, Starboard Value and Corvex Management. In 2017 and 2018, Goodwin ran campaigns for FOUR clients which resulted in the activists withdrawing their candidate and deciding NOT to run a proxy contest.
Our fully integrated team of lawyers—experts across all industries from life sciences to technology, to real estate—can augment existing counsel or step in directly to help companies negotiate a settlement quickly, or when necessary, aggressively fight to reach victory for our clients. When time cannot be wasted, we are fully prepared with the knowledge, insight, experience, data sets and contacts you need to reach a resolution quickly. Our defense work against three of the top ten activists in the past year alone speaks to our competence in this area. We were also ranked by Activist Insight Monthly rankings of law firms activism representation for representing the second most issuers in 2017. You can count on Goodwin for an experienced legal team when you need it most.
The ongoing convergence of capital and innovation requires advisors who are fluent in both worlds. At Goodwin, we have a global team that we believe is unique in BigLaw – a team that is equally proficient in advising the innovators and the investors across the technology, life sciences, real estate, private equity, and financial industries. Companies seeking to grow, increase liquidity for their investors or reduce their cost of capital regularly turn to Goodwin. We have one of the most active capital markets and public company practices in the United States, serving as outside counsel to public companies in a range of industries and who are listed on both U.S. and non-U.S. exchanges. We combine deep industry knowledge with broad technical expertise across all equity and debt securities and alternative investment structures. Since 2010, we have advised clients in more than 600 public offerings for over $145 billion in equity proceeds. We are consistently recognized by industry publications as one of the most active and innovative advisers for capital markets transactions and public companies.
Succeeding in the life sciences industry is as much about strategy and execution as it is about research and development. And with the breakneck pace of technology disrupting industries around the world, Goodwin’s depth of experience not only in the life sciences space, but also in collaboration with our technology, healthcare and private equity lawyers, makes our team exceptionally suited to address whatever the future brings. We partner with clients to embrace the promise and potential of innovation to make a profound and lasting impact.
Lawyers in our life sciences practice are deeply experienced in corporate governance, financing and M&A transactions, collaborations and licensing, regulatory matters, and intellectual property law. We understand the challenges of securing funding, safeguarding intellectual property, establishing partnerships, bringing new products to market, opening up new revenue streams, and protecting existing product lines. As part of our interdisciplinary approach, we collaborate with attorneys in our patent litigation, products litigation, employment and tax practices to protect client interests and to advocate on their behalf.
With a full service team of highly experienced lawyers resident in key life sciences hubs, our team helps clients find the strategic paths that foster growth and minimize risk across all phases of the corporate life cycle. Motivated by the knowledge that the work that we do with you is improving people’s lives, we serve as an extension of your team so you can focus on your core business.
As a growing technology company, your prospects are exciting and your challenges are unique – from securing funding, protecting IP, and navigating the regulatory environment, to differentiating yourself in the marketplace, managing customer acquisition and scaling your business. We get it. Our dedicated team brings a comprehensive, coordinated approach that interconnects business, new technologies and the law. Our depth of experience in the private equity space along with our technology, healthcare and life sciences lawyers makes Goodwin uniquely suited to harness the breakneck pace of technology. We partner with clients to embrace the promise and potential of innovation to make a profound and lasting impact.
Protect your company. Start off on the right foot. Goodwin’s full-service team advises on company formation and growth matters including incorporation, founders agreements, venture financing, intellectual property, licensing, employee contracts, benefits and beyond. We represent over 2,500 tech + emerging companies and 400 venture capital + private equity firms. This extensive company and investor client base allows us to leverage relationships and deep market knowledge on behalf of our clients.
More than 100 public companies trust Goodwin to serve as their counsel in a variety of corporate and litigation matters. We are primary outside counsel to public companies in many different industries, of all different sizes, and listed on both U.S. and non-U.S. exchanges. We help clients achieve their business strategies; meet high standards of transparency in disclosure, corporate governance and executive compensation; manage effective investor relations programs; and build credibility through disciplined interaction with capital markets participants, security holders, regulators, employees, ratings agencies, the media and the public at large. We integrate with experts from our M&A/Corporate Governance, ERISA & Executive Compensation, Securities Litigation and Tax Practices to provide full service representation for our public company clients.
The ongoing convergence of capital and innovation requires advisors who are fluent in both worlds. At Goodwin, we have a global team that we believe is unique in BigLaw – a team that is equally proficient in advising the innovators and the investors across the technology, life sciences, real estate, private equity, and financial industries. Companies seeking to grow, increase liquidity for their investors or reduce their cost of capital regularly turn to Goodwin. We have one of the most active capital markets and public company practices in the United States, serving as outside counsel to public companies in a range of industries and who are listed on both U.S. and non-U.S. exchanges. We combine deep industry knowledge with broad technical expertise across all equity and debt securities and alternative investment structures. Since 2010, we have advised clients in more than 600 public offerings for over $145 billion in equity proceeds. We are consistently recognized by industry publications as one of the most active and innovative advisers for capital markets transactions and public companies.
Succeeding in the life sciences industry is as much about strategy and execution as it is about research and development. And with the breakneck pace of technology disrupting industries around the world, Goodwin’s depth of experience not only in the life sciences space, but also in collaboration with our technology, healthcare and private equity lawyers, makes our team exceptionally suited to address whatever the future brings. We partner with clients to embrace the promise and potential of innovation to make a profound and lasting impact.
Lawyers in our life sciences practice are deeply experienced in corporate governance, financing and M&A transactions, collaborations and licensing, regulatory matters, and intellectual property law. We understand the challenges of securing funding, safeguarding intellectual property, establishing partnerships, bringing new products to market, opening up new revenue streams, and protecting existing product lines. As part of our interdisciplinary approach, we collaborate with attorneys in our patent litigation, products litigation, employment and tax practices to protect client interests and to advocate on their behalf.
With a full service team of highly experienced lawyers resident in key life sciences hubs, our team helps clients find the strategic paths that foster growth and minimize risk across all phases of the corporate life cycle. Motivated by the knowledge that the work that we do with you is improving people’s lives, we serve as an extension of your team so you can focus on your core business.
As a growing technology company, your prospects are exciting and your challenges are unique – from securing funding, protecting IP, and navigating the regulatory environment, to differentiating yourself in the marketplace, managing customer acquisition and scaling your business. We get it. Our dedicated team brings a comprehensive, coordinated approach that interconnects business, new technologies and the law. Our depth of experience in the private equity space along with our technology, healthcare and life sciences lawyers makes Goodwin uniquely suited to harness the breakneck pace of technology. We partner with clients to embrace the promise and potential of innovation to make a profound and lasting impact.
Protect your company. Start off on the right foot. Goodwin’s full-service team advises on company formation and growth matters including incorporation, founders agreements, venture financing, intellectual property, licensing, employee contracts, benefits and beyond. We represent over 2,500 tech + emerging companies and 400 venture capital + private equity firms. This extensive company and investor client base allows us to leverage relationships and deep market knowledge on behalf of our clients.
More than 100 public companies trust Goodwin to serve as their counsel in a variety of corporate and litigation matters. We are primary outside counsel to public companies in many different industries, of all different sizes, and listed on both U.S. and non-U.S. exchanges. We help clients achieve their business strategies; meet high standards of transparency in disclosure, corporate governance and executive compensation; manage effective investor relations programs; and build credibility through disciplined interaction with capital markets participants, security holders, regulators, employees, ratings agencies, the media and the public at large. We integrate with experts from our M&A/Corporate Governance, ERISA & Executive Compensation, Securities Litigation and Tax Practices to provide full service representation for our public company clients.
